AUY922 Completed Phase 1 / 2 Trials for Neoplasms, Hematologic / Cancer, Breast Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs